Tamar R Aprahamian1. 1. Department of Medicine-Renal Section, Boston University School of Medicine, 650 Albany Street, X536, Boston, MA 02118, USA. Electronic address: aprahami@bu.edu.
Abstract
OBJECTIVE: Despite the clinical prevalence of obesity, only recently has the importance of adipose tissue microenvironment been addressed at a molecular level. Here, I focused on the fat-derived cytokine adiponectin as a model system to understand the mechanism underlying adipose tissue vascularity, perfusion, inflammation, and systemic metabolic function. MATERIALS/ METHODS: Wild type, adiponectin-deficient, and adiponectin transgenic-overexpressing mice were maintained on chow diet or high fat/high sucrose diet for 32weeks. Vascularization of adipose tissue was examined by confocal microscopy and perfusion was determined by recovery of injected microspheres. Adipose tissue inflammation and systemic metabolic function were also assessed. RESULTS: Modest over-expression of adiponectin led to a marked increase in adipose tissue vascularity and perfusion, and this was associated with diminished hypoxia and an increase in vascular endothelial growth factor-A (VEGF-A) expression in the obese mice. Adiponectin over-expression in diet-induced obese mice also led to the virtual absence of macrophage infiltration and the elimination of crown-like structures. Adiponectin transgenic mice also displayed a remarkable sensitivity to insulin and diminished hepatic steatosis. Under the conditions of these experiments, adiponectin deficiency did not diminish adipose tissue perfusion or worsen metabolic function compared to wild type mice fed the high fat/high sucrose diet. CONCLUSION: These data demonstrate that increased circulating adiponectin levels, and the obese environment, are associated with increased adipose tissue vascularization and perfusion, and improved metabolic function under conditions of long term diet-induced obesity.
OBJECTIVE: Despite the clinical prevalence of obesity, only recently has the importance of adipose tissue microenvironment been addressed at a molecular level. Here, I focused on the fat-derived cytokine adiponectin as a model system to understand the mechanism underlying adipose tissue vascularity, perfusion, inflammation, and systemic metabolic function. MATERIALS/ METHODS: Wild type, adiponectin-deficient, and adiponectintransgenic-overexpressing mice were maintained on chow diet or high fat/high sucrose diet for 32weeks. Vascularization of adipose tissue was examined by confocal microscopy and perfusion was determined by recovery of injected microspheres. Adipose tissue inflammation and systemic metabolic function were also assessed. RESULTS: Modest over-expression of adiponectin led to a marked increase in adipose tissue vascularity and perfusion, and this was associated with diminished hypoxia and an increase in vascular endothelial growth factor-A (VEGF-A) expression in the obesemice. Adiponectin over-expression in diet-induced obesemice also led to the virtual absence of macrophage infiltration and the elimination of crown-like structures. Adiponectintransgenic mice also displayed a remarkable sensitivity to insulin and diminished hepatic steatosis. Under the conditions of these experiments, adiponectin deficiency did not diminish adipose tissue perfusion or worsen metabolic function compared to wild type mice fed the high fat/high sucrose diet. CONCLUSION: These data demonstrate that increased circulating adiponectin levels, and the obese environment, are associated with increased adipose tissue vascularization and perfusion, and improved metabolic function under conditions of long term diet-induced obesity.
Authors: Almudena Gómez-Hernández; Yolanda F Otero; Natalia de las Heras; Oscar Escribano; Victoria Cachofeiro; Vicente Lahera; Manuel Benito Journal: Endocrinology Date: 2012-01-17 Impact factor: 4.736
Authors: Julia Yuen Shan Tsang; Daxu Li; Derek Ho; Jiao Peng; Aimin Xu; Jonathan Lamb; Yan Chen; Paul Kwong Hang Tam Journal: Int Immunopharmacol Date: 2010-11-19 Impact factor: 4.932
Authors: Jian Cao; Stephen J Peterson; Komal Sodhi; Luca Vanella; Ignazio Barbagallo; Luigi F Rodella; Michal L Schwartzman; Nader G Abraham; Attallah Kappas Journal: Hypertension Date: 2012-07-02 Impact factor: 10.190
Authors: Giuseppe Straface; Tamar Aprahamian; Andrea Flex; Eleonora Gaetani; Federico Biscetti; Roy C Smith; Giovanni Pecorini; Enrico Pola; Flavia Angelini; Egidio Stigliano; John J Castellot; Douglas W Losordo; Roberto Pola Journal: J Cell Mol Med Date: 2008-07-26 Impact factor: 5.310
Authors: O Gealekman; N Guseva; K Gurav; A Gusev; C Hartigan; M Thompson; S Malkani; S Corvera Journal: Diabetologia Date: 2012-07-31 Impact factor: 10.122
Authors: Kate E Therkelsen; Alison Pedley; Klara J Rosenquist; Udo Hoffmann; Joseph M Massaro; Joanne M Murabito; Caroline S Fox Journal: Obesity (Silver Spring) Date: 2015-12-23 Impact factor: 5.002
Authors: Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Maria A Zuriaga; Susan MacLauchlan; Tamar R Aprahamian; Kenneth Walsh Journal: J Biol Chem Date: 2014-04-17 Impact factor: 5.157